Director and Professor of Chemotherapy Department

Clinical Interests

Chemotherapy & immunotherapy of common malignancies, such as lung cancer, breast cancer, malignant lymphoma.

Research Interests

l Therapy of refractory lymphoma

l Anti-angiogenesis therapy combined with chemotherapy of NSCLC

l Targeting therapy of chemotherapy-resistant malignancies

l Mechanism of neoplasm’s chemotherapy-resistance

l Principal Investigator appointed by SDA for many clinical trials of new anti-cancer drugs

Education

l Tianjin Medical College, B.A. 1984

l University of California San Francisco, Postdoctal Fellow

Honors

l Tianjin Municipal Sciences and Technology Advanced Awards, 2000

l Tianjin Health Bureau Science and Technology Awards, 1999

Other Responsibilities

Member, Chinese Anti-cancer Association (Gastric Cancer Committee and Sarcoma Committee), Member, Tianjin Expert Association of Medicine and Pharmacology, Guest professor of the Medical College of Nan Kai University, Member, Editorial Board of the Journal of Chinese Oncology, Member of the Editorial Board of Chinese Journal of Current Clinical Medicine.

Publications

 Over 40 articles have been published in related professional journals; Author or coauthor, book chapters, editorials and invited commentaries;Over 20 scientific presentations in the meetings at home and abroad;Invited lecturer or professor on many occasions.